Dexmedetomidine: Applications in pediatric critical care and pediatric anesthesiology

Pediatric Critical Care Medicine

Volumn 8, Issue 2, 2007, Pages 115-131

  Tobias, Joseph D ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Dexmedetomidine; Emergence delirium; Opioid tolerance and withdrawal; Proceduralsedation; 2 adrenergic agonist

Indexed keywords

ALFENTANIL; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2B ADRENERGIC RECEPTOR; ATIPAMEZOLE; ATROPINE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBON DIOXIDE; CLONIDINE; DESFLURANE; DEXMEDETOMIDINE; DIGOXIN; ENFLURANE; FENTANYL; IMIDAZOLE; ISOFLURANE; KETAMINE; METHOXAMINE; MIDAZOLAM; MORPHINE; NITROUS OXIDE; OPIATE; PETHIDINE; PHENYLEPHRINE; PROPOFOL; PYRIDOSTIGMINE; REMIFENTANIL; SUXAMETHONIUM;

AGITATION; ANALGESIA; ANTICONVULSANT ACTIVITY; ARTIFICIAL VENTILATION; BRADYCARDIA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DATA BASE; DIAPHORESIS; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG METABOLISM; DRUG WITHDRAWAL; GASTROINTESTINAL MOTILITY; GENERAL ANESTHESIA; HEART AFTERLOAD; HEART ARREST; HEART OUTPUT; HEART RATE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPOTENSION; INFORMATION PROCESSING; INTENSIVE CARE; INVASIVE PROCEDURE; ISCHEMIA; LUNG MINUTE VOLUME; MEMORY; NEUROPROTECTION; NONHUMAN; PEDIATRIC ANESTHESIA; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; RECALL; RESPIRATION DEPRESSION; RESPIRATORY FUNCTION; REVIEW; SEDATION; SEIZURE; SHIVERING; SIDE EFFECT; TACHYCARDIA; VASOCONSTRICTION; WITHDRAWAL SYNDROME;

EID: 34147136551     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PCC.0000257100.31779.41     Document Type: Review

References (124)

1. 2-adrenoceptor agonist. Eur J Pharmacol 1998; 150:9-14
2. 2 agonist in the locus ceruleus of the rat. Pharmacol Biochem Behav 1992; 43:723-727
3. 2 agonist in the rat. J Pharmacol Exp Ther 1992; 263:1046-1050
4. 2 adrenergic agonist dexmedetomidine in the locus ceruleus of the rat. Anesthesiology 1994; 81:1527-1534
5. 2+ channels due to phosphorylation by cAMP-dependent protein kinase. Nature 1993; 364:240-243
6. 2 agonist is mediated in the locus ceruleus in rats. Anesthesiology 1992; 76:948-952
7. Doze VA, Chen BX, Maze M: Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 1989; 71:75-79
8. 2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98:428-436
9. Hall JE, Uhrich TD, Barney JA, et al: Sedative, amnestic, and analgesic properties of small-dose dexmedetomidine infusions. Anesth Analg 2000; 90:699-705
10. Belleville JP, Ward DS, Bloor BC, et al: Effects of intravenous dexmedetomidine in humans: I Sedation, ventilation, and metabolic rate. Anesthesiology 1992; 77:1125-1133
11. Venn RM, Bradshaw CJ, Spencer R, et al: Preliminary UK experience of dexmedetomidine, a novel agent for postoperative sedation in the intensive care unit. Anaesthesia 1999; 54:1136-1142
12. Dyck JB, Shafer SL: Dexmedetomidine pharmacokinetics and pharmacodynamics. Anesth Pharm Rev 1993; 1:238-245
13. Cunningham FE, Baughman VL, Tonkovich L, et al: Pharmacokinetics of dexmedetomidine in patients with hepatic failure. Abstr. Clin Pharmacol Ther 1999; 65:128
14. De Wolf AM, Fragen RJ, Avram MJ, et al: The pharmacokinetics of dexmedetomidine in volunteers with severe renal impairment. Anesth Analg 2001; 93:1205-1209
15. Venn RM, Karol MD, Grounds RM: Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth 2002; 88:669-675
16. Petroz GC, Sikich N, James M, et al: A phase 1, two center study of the pharmacokinetics and pharmacodynamics of dexmedetomidine in children. Anesthesiology, In Press
17. Rodarte A, Diaz SM, Foley J, et al: The pharmacokinetics of dexmedetomidine in post-surgical pediatric intensive care unit patients: A preliminary study. Abstr. Anesthesiology 2003; 99:A423
18. Su F, Nicolson S, Adamson PC, et al: The pharmacokinetics and pharmacodynamics of dexmedetomidine in infants following open heart surgery. Abstr. Crit Care Med 2005; 33:A6
19. Bloor BC, Ward DS, Belleville JP, et al: Effects of intravenous dexmedetomidine in humans, II: Hemodynamic changes. Anesthesiology 1992; 77:1134-1142
20. Peden CJ, Cloote AH, Stratford N, et al: The effect of intravenous dexmedetomidine premedication on the dose requirement of propofol to induce loss of consciousness in patients receiving alfentanil. Anaesthesia 2001; 56:408-413
21. Ingersoll-Weng E, Manecke GR, Thistlethwaite PA: Dexmedetomidine and cardiac arrest. Anesthesiology 2004; 100:738-739
22. Berkenbosch JW, Tobias JD: Development of bradycardia during sedation with dexmedetomidine in an infant concurrently receiving digoxin. Pediatr Crit Care Med 2003; 4:203-205
23. Scheinin H, Jaakola ML, Sjovall S, et al: Intramuscular dexmedetomidine as premedication for general anesthesia. A comparative multicenter study. Anesthesiology 1993; 78:1065-1075
24. Khan ZP, Munday IT, Jones RM: Effects of dexmedetomidine on isoflurane requirements in health volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. Br J Anaesth 1999; 83:372-380
25. Deutsch E, Tobias JD: Hemodynamic and respiratory changes following dexmedetomidine administration during general anesthesia: Sevoflurane vs. desflurane. Pediatr Anesth, In Press
26. Talke P, Li J, Jain U, et al: Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology 1995; 82:620-635
27. Ruesch S, Levy JH: Treatment of persistent tachycardia with dexmedetomidine during off-pump cardiac surgery. Anesth Analg 2002; 95:316-318
28. Housmans PR: Effects of dexmedetomidine on contractility, relaxation, and intracellular calcium transients of isolated ventricular myocardium. Anesthesiology 1990; 73:919-922
29. Talke P, Richardson CA, Scheinin M, et al: Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesth Analg 1997; 85:1136-1142
30. Talke P, Chen R, Thomas B, et al: The hemodynamic and adrenergic effects of perioperative dexmedetomidine infusion after vascular surgery. Anesth Analg 2000; 90:834-839
31. Mukhtar AM, Obayah EM, Hassona AM: The use of dexmedetomidine in pediatric cardiac surgery. Anesth Analg 2006; 103:52-56
32. Blake DW, Ludbrook J, Van Leeuwen AF: Dexmedetomidine and haemodynamic responses to acute central hypovolaemia in conscious rabbits. Clin Exp Pharm Physiol 2000; 27:801-809
33. Blake DW: Dexmedetomidine and hemodynamic responses to simulated hemorrhage in experimental heart failure. Anesth Analg 2000; 91:1112-1117
34. Talke P, Li J, Jain U, et al: The study of Perioperative Ischemia Research Group. Effects of perioperative dexmedetomidine infusion in patients undergoing vascular surgery. Anesthesiology 1995; 82:620-633
35. Oliver MF, Goldman L, Julian DG, et al: Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary artery disease: The European Mivazerol Trial (EMIT). Anesthesiology 1999; 91:951-961
36. Roekaerts PMH, Prinzen FW, De Lange S: Beneficial effects of dexmedetomidine on ischaemic myocardium of anaesthetized dogs. Br J Anaesth 1996; 77:427-429
37. Willigers HM, Prinzen FW, Roekaerts PM, et al: Dexmedetomidine decreases perioperative myocardial lactate release in dogs. Anesth Analg 2003; 96:657-664
38. Guo H, Takahashi S, Cho S, et al: The effects of dexmedetomidine on left ventricular function during hypoxic and reoxygenation in isolated rat hearts. Anesth Analg 2005; 100:629-635
39. Kamibayashi T, Mammoto T, Hayashi Y, et al: Further characterization of the receptor mechanism involved in the antidysrhythmic effect of dexmedetomidine on halothane/ epinephrine dysrhythmias in dogs. Anesthesiology 1995; 83:1082-1089
40. Kastner SBR, Kull S, Kutter APN, et al: Cardiopulmonary effects of dexmedetomidine in sevoflurane-anesthetized sheep with and without nitric oxide inhalation. Am J Vet Res 2005; 66:1496-1502
41. Ebert T, Hall J, Barney J, et al: The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000; 93:382-394
42. Bol CJJG, Danhoff M, Stanski DR, et al: Pharmacokinetic-pharmacodynamic characterization of the cardiovascular, hypnotic, EEG, and ventilatory responses to dexmedetomidine in the rat. J Pharm Exp Ther 1997; 283:1051-1058
43. Nguyen D, Abdul-Rasool I, Ward D, et al: Ventilatory effects of dexmedetomidine, atipamezol, and isoflurane in dogs. Anesthesiology 1992; 76:573-579
44. Nishida T, Nishimura M, Kagawa K, et al: The effects of dexmedetomidine on the ventilatory response to hypercapnia in rabbits. Intensive Care Med 2002; 28:969-975
45. Hsu YW, Cortinez LI, Robertson KM, et al: Dexmedetomidine pharmacodynamics: Crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology 2004; 101:1066-1076
46. 2- agonist, does not potentiate the cardiorespiratory depression of alfentanil in the rat. Anesthesiology 1990; 72:882-888
47. Ho AMH, Chen S, Karmakar MK: Central apnoea after balanced general anaesthesia that included dexmedetomidine. Br J Anaesth 2005; 95:773-775
48. 2- adrenoceptor agonist dexmedetomidine on the bronchoconstriction in dogs. Anesthesiology 2004; 100:359-363
49. 2-adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects. Anesthesiology 2003; 98:428-436
50. Doze VA, Chen BX, Maze M: Dexmedetomidine produces a hypnotic-anesthetic action in rats via activation of central alpha-2 adrenoceptors. Anesthesiology 1898; 71:75-79
51. Talke P, Tong C, Lee HW, et al: Effect of dexmedetomidine on lumbar cerebrospinal fluid pressure in humans. Anesth Analg 1997; 85:358-364
52. Zornow MH, Scheller MS, Sheehan PB, et al: Intracranial pressure effects of dexmedetomidine in rabbits. Anesth Analg 1992; 75:232-237
53. Vartiainen J, MacDonald E, Urtri A, et al: Dexmedetomidine-induced ocular hypotension in rabbits with normal or elevated intracranial pressure. Invest Opthalmol Vis Sci 1992; 33:2019-2023
54. 2-agonist, on cerebral blood flow and oxygen consumption during halothane anesthesia in dogs. Anesth Analg 1990; 71:125-129
55. Prielipp RC, Wall MH, Tobin JR, et al: Dexmedetomidine-induced sedation in volunteers decreases regional and global cerebral blood flow. Anesth Analg 2002; 95:1052-1059
56. Mirski MAZ, Rossell LA, McPherson RW, et al: Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy. Anesthesiology 1994; 81:1422-1428
57. Miyazaki Y, Adachi T, Kurata J, et al: Dexmedetomidine reduces seizure threshold during enflurane anaesthesia in cats. Br J Anaesth 1999; 82:935-937
58. Whittington RA, Virag L, Vulliemoz Y, et al: Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology 2002; 97:693-700
59. 2-adrenoceptor for controlling convulsions. Anesth Analg 2005; 100:687-696
60. 2-adrenergic antagonist atipamezole. Anesthesiology 1991; 75:328-332
61. Kuhmonen J, Pokorny J, Miettinen R, et al: Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology 1997; 87:371-377
62. Kuhmonen J, Haapalinna A, Sivenius J: Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat. J Neural Transm 2001; 108:261-271
63. 2-adrenoceptor agonists on perinatal excitotoxic brain injury. Anesthesiology 2002; 96:134-141
64. 2-agonist dexmedetomidine on cerebral neurotransmitter concentrations during cerebral ischemia in rats. Anesthesiology 2002; 96:450-457
65. Dahmani S, Rouelle D, Gressens P, et al: Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions. Anesthesiology 2005; 103:969-977
66. Jalonen J, Hynynen M, Kuitunen A, et al: Dexmedetomidine as an anesthetic agent in coronary artery bypass grafting. Anesthesiology 1997; 86:331-345
67. Doufas AG, Lin CM, Suleman MI, et al: Dexmedetomidine and meperidine actively reduce the shivering threshold in humans. Stroke 2003; 34:1218-1223
68. Asai T, Mapleson WW, Power I: Differential effects of clonidine and dexmedetomidine on gastric emptying and gastrointestinal transit in the rat. Br J Anaesth 1997; 78:301-307
69. Herbert MK, Roth-Goldbrunner S, Holzer P, et al: Clonidine and dexmedetomidine potently inhibit peristalsis in the guinea pig ileum in vitro. Anesthesiology 2002; 97:1491-1499
70. Maze M, Virtanen R, Daunt D, et al: Effects of dexmedetomidine, a novel imidazole sedation-anesthetic agent, on adrenal steroidogenesis: In vivo and in vitro studies. Anesth Analg 1991; 73:204-208
71. Venn RM, Bryant A, Hall GM, et al: Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in postoperative patients needing sedation in the intensive care unit. Br J Anaesth 2001; 86:650-656
72. Nishina K, Akamatsu H, Mikawa K, et al: The effects of clonidine and dexmedetomidine on human neutrophil function. Anesth Analg 1999; 88:452-458
73. Taniguchi T, Kidani Y, Kanakura H, et al: Effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004; 32:1322-1326
74. Weinger MB, Partridge BL, Henry AF: Dexmedetomidine does not modify the neuromuscular blocking action of vecuronium in the anaesthetized rat. Br J Anaesth 1995; 74:455-457
75. Talke PO, Caldwell JE, Richardson CA, et al: The effects of dexmedetomidine on neuromuscular blockade in human volunteers. Anesth Analg 1999; 88:633-639
76. Tobias JD, Berkenbosch JW: Initial experience with dexmedetomidine in paediatric-aged patients. Paediatr Anaesth 2002; 12:171-175
77. Tobias JD, Berkenbosch JW, Russo P: Additional experience with dexmedetomidine in pediatric patients. South Med J 2003; 96:871-875
78. Ibacache ME, Munoz HR, Brandes V, et al: Single-dose dexmedetomidine reduces agitation after sevoflurane anesthesia in children. Anesth Analg 2004; 98:60-63
79. Hanafy MA, El-Zahaby HM, Swellam AM: The effect of dexmedetomidine on the emergence agitation associated with desflurane anaesthesia in children. Eg J Anaesth 2004; 20:135-140
80. Guler G, Akin A, Tosum Z et al: Single-dose dexmedetomidine reduces agitation and provides smooth extubation after pediatric adenotonsillectomy. Pediatr Anesth 2005; 15:762-766
81. Skukry M, Clyde MC, Kalarickal PL, et al: Does dexmedetomidine prevent emergence delirium in children after sevoflurane-based general anesthesia. Pediatr Anesth 2005; 15:1098-1104
82. Isik B, Arslan M, Tunga AD, et al: Dexmedetomidine decreases emergence agitation in pediatric patients after sevoflurane anesthesia without surgery. Pediatr Anesth, In Press
83. Tobias JD, Berkenbosch JW: Sedation during mechanical ventilation in infants and children: Dexmedetomidine vs. midazolam. South Med J 2004; 97:451-455
84. Wheeler A, Bothwell M, Tobias JD: Prevention of medication withdrawal following laryngotracheoplasty. Am J Pain Manage 2005; 15:15-21
85. Hammer GB, Philip BM, Schroeder AR, et al: Prolonged infusion of dexmedetomidine for sedation following tracheal resection. Pediatr Anesth 2005; 15:616-620
86. Chrysostomou C, Zeballos T: Use of dexmedetomidine in a pediatric heart transplant patient. Pediatr Cardiol 2005; 26:651-654
87. Chrysostomou C, Di Filippo S, Manrique AM, et al: Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med 2006; 7:126-131
88. Nichols DP, Berkenbosch JW, Tobias JD: Rescue sedation with dexmedetomidine for diagnostic imaging: A preliminary report. Pediatr Anesth 2005; 15:199-203
89. Koroglu A, Demirbilek S, Teksan H, et al: Sedative, hemodynamic and respiratory effects of dexmedetomidine in children undergoing magnetic resonance imaging examination: Preliminary results. Br J Anaesth 2005; 94:821-824
90. Berkenbosch JW, Wankum P, Tobias JD: Prospective evaluation of dexmedetomidine for noninvasive procedural sedation in children. Pediatr Crit Care Med 2005; 6:435-439
91. Koroglu A, Teksan H, Sagir O, et al: A comparison of the sedative, hemodynamic and respiratory effects of dexmedetomidine and propofol in children undergoing magnetic resonance imaging. Anesth Analg 2006; 103:63-67
92. Mason KP, Zgleszewski SE, Dearden JL, et al: Dexmedetomidine for pediatric sedation for computed tomography imaging studies. Anesth Analg 2006; 103:57-62
93. Shukry M, Ramadhyani U: Dexmedetomidine as the primary sedative agent for brain radiation therapy in a 21-month old child. Pediatr Anesth 2005; 15:241-242
94. Young ET: Dexmedetomidine sedation in a pediatric cardiac patient scheduled for MRI. Can J Anaesth 2005; 52:730-732
95. Fahy CJ, Okumura M: Sedation for paediatric stereotactic radiosurgery: The dexmedetomidine experience. Anaesth Intensive Care 2004; 32:809-811
96. Kunisawa T, Iwasaki H: Sedation of a pediatric patient using dexmedetomidine for day-care MRI. Masui Japan J Anesth 2005; 54:1047-1050
97. Luscri N, Tobias JD: Monitored anesthesia care with a combination of ketamine and dexmedetomidine during magnetic resonance imaging in three children with trisomy 21 and obstructive sleep apnea. Pediatr Anesth 2006; 16:782-786
98. Jooste EH, Ohkawa S, Sun LS: Fiberoptic intubation with dexmedetomidine in two children with spinal cord impingement. Anesth Analg 2005; 101:1238-1248
99. Avitsian R, Lin J, Lotto M, et al: Dexmedetomidine and awake fiberoptic intubation for possible cervical spine myelopathy: A clinical series. J Neurosurg Anesth 2005; 17:97-99
100. Grant SA, Breslin DS, MacLeod DB, et al: Dexmedetomidine infusion for sedation during fiberoptic intubation: A report of three cases. J Clin Anesth 2004; 16:124-126
101. Munro HM, Tirotta CF, Felix DE, et al: Initial experience with dexmedetomidine for diagnostic and interventional cardiac catheterization in children. Pediatr Anesth, In Press
102. Jalowiecki P, Rudner R, Gonciarz M, et al: Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy. Anesthesiology 2005; 103:269-273
103. Alhashemi JA: Dexmedetomidine vs. midazolam for monitored anaesthesia care during cataract surgery. Br J Anaesth 2006; 96:722-726
104. Scher CS, Gitlin MC: Dexmedetomidine and low-dose ketamine provide adequate sedation for awake fibreoptic intubation. Can J Anesth 2003; 50:607-610
105. Tosun Z, Akin A, Guler G, et al: Dexmedetomidine-ketamine and propofol-ketamine combinations for anesthesia in spontaneously breathing pediatric patients undergoing cardiac catheterization. J Cardiothor Vasc Anesth, In Press
106. Levanen J, Makela ML, Scheinin H: Dexmedetomidine premedication attenuates ketamine-induced cardiostimulatory effects and postanesthetic delirium. Anesthesiology 1995; 82:1117-1125
107. Ard J, Doyle W, Bekker A: Awake craniotomy with dexmedetomidine in pediatric patients. J Neurosurg Anesth 2003; 15:263-266
108. Everett LL, Van Rooyen IF, Warner MH, et al: Use of dexmedetomidine in awake craniotomy in adolescents: Report of two cases. Pediatr Anesth 2006; 16:338-342
109. Riihioja P, Jaatinen P, Oksanen H, et al: Dexmedetomidine, diazepam, and propranolol in the treatment of alcohol withdrawal symptoms in the rat. Alcohol Clin Exp Res 1997; 21:804-808
110. Riihioja P, Jaatinen P, Haapalinna A, et al: Effects of dexmedetomidine on rat loceus coeruleus and ethanol withdrawal symptoms during intermittent ethanol exposure. Alcohol Clin Exp Res 1999; 23:432-438
111. Riihioja P, Jaatinen P, Oksanen H, et al: Dexmedetomidine alleviates ethanol withdrawal symptoms in the rat. Alcohol 1997; 14:537-544
112. Riihioja P, Jaatinen P, Haapalinna, et al: Prevention of ethanol-induced sympathetic overactivity and degeneration by dexmedetomidine. Alcohol 1995; 12:439-446
113. Maccioli GA: Dexmedetomidine to facilitate drug withdrawal. Anesthesiology 2003; 98:575-577
114. Multz AS: Prolonged dexmedetomidine infusion as an adjunct in treating sedation-induced withdrawal. Anesth Analg 2003; 96:1054-1055
115. Finkel JC, Elrefai A: The use of dexmedetomidine to facilitate opioid and benzodiazepine detoxification in an infant. Anesth Analg 2004; 98:1658-1659
116. Baddigam K, Russo P, Russo J, et al: Dexmedetomidine in the treatment of withdrawal syndromes in cardiothoracic surgery patients. J Intensive Care Med 2005; 20:118-123
117. Finkel JC, Johnson YJ, Quezado YMN: The use of dexmedetomidine to facilitate acute discontinuation of opioids alter cardiac transplantation in children. Crit Care Med 2005; 33:2110-2112
118. Tobias JD: Dexmedetomidine to treat opioid withdrawal in infants and children following prolonged sedation in the Pediatric ICU. J Opioid Manage 2006; 2:201-206
119. Khasawinah TA, Ramirez A, Berkenbosch JE, et al: Preliminary experience with dexmedetomidine in the treatment of cyclic vomiting syndrome. Am J Ther 2003; 10:303-307
120. Zub D, Berkenbosch JW, Tobias JD: Preliminary experience with oral dexmedetomidine for procedural and anesthetic premedication. Pediatr Anesth 2005; 15:932-938
121. Tobias JD: Bier block using dexmedetomidine and lidocaine in an adolescent with complex regional pain syndrome type I. Am J Pain Manage 2006; 16:84-87
122. Easley RB, Brady KM, Tobias JD: Dexmedetomidine for the treatment of postanesthetic shivering in children. Pediatr Anesth (submitted)
123. Tobin JR, Shafer SL, Davis PJ: Pediatric research and scholarship: Another Gordian knot? Anesth Analg 2006; 103:43-47
124. Rosen DA, Daume JT: Short duration large dose dexmedetomidine in a pediatric patient during procedural sedation. Anesth Analg 2006; 103:68-69